IndexIQ Advisors’s Avanos Medical AVNS Stock Holding History

IndexIQ Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$409K	Buy	12,208 +2,553	+26%	+$82.2K	0.01%	547
2021 Q4	$335K	Sell	9,655 -624	-6%	-$20.2K	0.01%	895
2021 Q3	$321K	Buy	10,279 +1,030	+11%	+$34.9K	0.01%	967
2021 Q2	$336K	Buy	9,249 +22	+0.2%	+$910	0.01%	940
2021 Q1	$404K	Buy	+9,227	New	+$433K	0.01%	599

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IndexIQ Advisors's AVNS Position: Q1 2022 in Review

IndexIQ Advisors increased its Avanos Medical (AVNS) stake by 26% in Q1 2022, buying an estimated $82.2K and bringing the position to 12,208 shares worth $409K. The position accounts for 0.01% of the portfolio, ranked #547.

IndexIQ Advisors first reported a position in AVNS in Q1 2021 and has held it in 5 quarters since. 299 funds tracked by Wall St. Rank hold AVNS as of Q1 2022.

IndexIQ Advisors held 12,208 shares of Avanos Medical worth $409K as of Q1 2022.
IndexIQ Advisors bought 2,553 Avanos Medical shares in Q1 2022, an estimated $82.2K.
Avanos Medical made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #547 holding.
IndexIQ Advisors first reported a position in Avanos Medical in Q1 2021 and has held it in 5 quarters since.
299 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.